ClearPoint Neuro, Inc.CLPTEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CLPT Q3 2025 Key Financial Metrics
Revenue
$8.9M
Gross Profit
$5.6M
Operating Profit
$-5.3M
Net Profit
$-5.9M
Gross Margin
63.2%
Operating Margin
-59.5%
Net Margin
-66.5%
YoY Growth
9.1%
EPS
$-0.21
Financial Flow
ClearPoint Neuro, Inc. Q3 2025 Financial Summary
ClearPoint Neuro, Inc. reported revenue of $8.9M for Q3 2025, with a net profit of $-5.9M (-66.5% margin). Cost of goods sold was $3.3M, operating expenses totaled $10.9M.
Key Financial Metrics
| Total Revenue | $8.9M |
|---|---|
| Net Profit | $-5.9M |
| Gross Margin | 63.2% |
| Operating Margin | -59.5% |
| Report Period | Q3 2025 |
ClearPoint Neuro, Inc. Annual Revenue by Year
ClearPoint Neuro, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $31.4M).
| Year | Annual Revenue |
|---|---|
| 2024 | $31.4M |
| 2023 | $24.0M |
| 2022 | $20.6M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8M | $7.6M | $7.9M | $8.1M | $7.8M | $8.5M | $9.2M | $8.9M |
| YoY Growth | 31.6% | 40.6% | 32.1% | 41.0% | 14.1% | 11.1% | 17.3% | 9.1% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $42.7M | $53.6M | $52.6M | $40.2M | $39.2M | $30.1M | $62.9M | $60.4M |
| Liabilities | $21.5M | $19.1M | $20.4M | $11.2M | $13.8M | $10.1M | $43.1M | $44.5M |
| Equity | $21.2M | $34.6M | $32.1M | $29.0M | $25.4M | $20.0M | $19.7M | $15.9M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-1.2M | $-3.8M | $-2.7M | $-1.2M | $-1.2M | $-6.2M | $-2.6M | $-3.1M |